http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-111684284-A
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d32b0e3b097c260fe8dd073c987e71d1 |
classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-224 |
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-86 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-56 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-86 |
filingDate | 2019-02-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_89763b97de710e3fc79cf6e2627a55f4 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a1d86b6f746e9301f8b648d31e647da8 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c933787898f565f175737e80fc7ea90f |
publicationDate | 2020-09-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | CN-111684284-A |
titleOfInvention | Method for diagnosing hemostatic disorders using activated carbon |
abstract | The present application provides a method for in vitro diagnosis of a hemostatic disorder in a plasma sample obtained from a subject, the method comprising the steps of: a) contacting a plasma sample obtained from the subject with activated carbon; b) recovering the plasma sample from the activated carbon; c) determining the clotting ability of the plasma sample obtained in step (b), wherein the ability of the plasma sample to clot is indicative of the presence, progression or severity of the subject to cease blood disorders, and optionally the nature of hemostatic disorders. |
isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-113670692-A |
priorityDate | 2018-02-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 191.